Mount Sinai study points to efficacy of convalescent COVID-19 plasma treatment


A team of researchers at Mount Sinai and the Johns Hopkins Bloomberg School of Public Health found that 39 COVID-19 patients who were treated with convalescent COVID-19 plasma had better outcomes than patients who were not treated with convalescent plasma. Notably, patients improved both in terms of lower oxygenation requirements and in overall mortality. Read more here and here.

0 comments